[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[2]
|
Galun, D., Mijac, D., Filipovic, A., Bogdanovic, A., Zivanovic, M. and Masulovic, D. (2022) Precision Medicine for Hepatocellular Carcinoma: Clinical Perspective. Journal of Personalized Medicine, 12, Article 149.
https://doi.org/10.3390/jpm12020149
|
[3]
|
Ahn, J.C., Qureshi, T.A., Singal, A.G., Li, D. and Yang, J.D. (2021) Deep Learning in Hepatocellular Carcinoma: Current Status and Future Perspectives. World Journal of Hepatology, 13, 2039-2051.
https://doi.org/10.4254/wjh.v13.i12.2039
|
[4]
|
Seehofer, D., Sucher, R. and Denecke, T. (2022) Resection and Transplantation for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma. Der Radiologe, 62, 210-218. https://doi.org/10.1007/s00117-021-00962-9
|
[5]
|
Giuffrè, M., Zuliani, E., Visintin, A., et al. (2022) Predictors of Hepatocellular Carcinoma Early Recurrence in Patients Treated with Surgical Resection or Ablation Treatment: A Sin-gle-Center Experience. Diagnostics, 12, Article 2517.
https://doi.org/10.3390/diagnostics12102517
|
[6]
|
Llovet, J.M., Kelley, R.K., Villanueva, A., et al. (2021) Hepato-cellular Carcinoma. Nature Reviews Disease Primers, 7, Article No. 6. https://doi.org/10.1038/s41572-020-00240-3
|
[7]
|
Bzeizi, K.I., Maheeba, A., Kota, V., Alqahthani, S.A. and Dieter, B. (2022) Hepatocellular Carcinoma Recurrence and Mortality Rate Post Liver Transplantation: Meta-Analysis and Sys-tematic Review of Real-World Evidence. Cancers, 14, Article 5114. https://doi.org/10.3390/cancers14205114
|
[8]
|
Matsubara, K. and Tokino, T. (1990) Integration of Hepatitis B Vi-rus DNA and Its Implications for Hepatocarcinogenesis. Molecular Biology in Medicine, 7, 243-260.
|
[9]
|
Ringlander, J., Skoglund, C., Prakash, K., et al. (2020) Deep Sequencing of Liver Explant Transcriptomes Reveals Extensive Expression from Integrated Hepatitis B Virus DNA. Journal of Viral Hepatitis, 27, 1162-1170.
https://doi.org/10.1111/jvh.13356
|
[10]
|
Chiang, C.J., Yang, Y.W., You, S.L., Lai, M.S. and Chen, C.J. (2013) Thirty-Year Outcomes of the National Hepatitis B Immunization Program in Taiwan. JAMA, 310, 974-976. https://doi.org/10.1001/jama.2013.276701
|
[11]
|
McGlynn, K.A., Petrick, J.L. and London, W.T. (2015) Global Ep-idemiology of Hepatocellular Carcinoma: An Emphasis on Demographic and Regional Variability. Clinics in Liver Dis-ease, 19, 223-238.
https://doi.org/10.1016/j.cld.2015.01.001
|
[12]
|
Song, C., Lv, J., Liu, Y., et al. (2019) Associations between Hepati-tis B Virus Infection and Risk of All Cancer Types. JAMA Network Open, 2, e195718. https://doi.org/10.1001/jamanetworkopen.2019.5718
|
[13]
|
李韦杰, 徐东平, 韩佳琪, 等. 乙型肝炎自然进程中血清HBV RNA的动态变化及其与肝组织HBV cccDNA的关系[J]. 标记免疫分析与临床, 2019, 26(9): 1445-1451, 1460.
|
[14]
|
易永祥. 乙型肝炎病毒的分子流行病学研究进展[J]. 新发传染病电子杂志, 2020, 5(1): 1-7.
|
[15]
|
Petersen, J., Thompson, A.J. and Levrero, M. (2016) Aiming for Cure in HBV and HDV Infection. Journal of Hepatology, 65, 835-848. https://doi.org/10.1016/j.jhep.2016.05.043
|
[16]
|
Biological Agents (2012) IARC Monogr Eval Carcinog Risks Hum. 100, 1-441.
|
[17]
|
周泽文, 刘颖春, 向邦德, 余红平. 原发性肝癌的全球展望: 流行情况、危险因素和人群归因分值[J]. 中国癌症防治杂志, 2021, 13(1): 14-21.
|
[18]
|
Ng, J. and Wu, J. (2012) Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas in the United States: Similarities and Differences. Hepatitis Monthly, 12, e7635. https://doi.org/10.5812/hepatmon.7635
|
[19]
|
Huang, A.C., Mehta, N., Dodge, J.L., Yao, F.Y. and Ter-rault, N.A. (2018) Direct-Acting Antivirals Do Not Increase the Risk of Hepatocellular Carcinoma Recurrence after Lo-cal-Regional Therapy or Liver Transplant Waitlist Dropout. Hepatology, 68, 449-461. https://doi.org/10.1002/hep.29855
|
[20]
|
Dai, Y., Huang, K., Zhang, B., Zhu, L. and Xu, W. (2017) Aflatoxin B1-Induced Epigenetic Alterations: An Overview. Food and Chemical Toxicology, 109, 683-689. https://doi.org/10.1016/j.fct.2017.06.034
|
[21]
|
Qi, L.N., Bai, T., Chen, Z.S., et al. (2015) The P53 Mutation Spec-trum in Hepatocellular Carcinoma from Guangxi, China: Role of Chronic Hepatitis B Virus Infection and Aflatoxin B1 Exposure. Liver International, 35, 999-1009.
https://doi.org/10.1111/liv.12460
|
[22]
|
Kensler, T.W., Qian, G.S., Chen, J.G. and Groopman, J.D. (2003) Transla-tional Strategies for Cancer Prevention in Liver. Nature Reviews Cancer, 3, 321-329. https://doi.org/10.1038/nrc1076
|
[23]
|
Turati, F., Galeone, C., Rota, M., et al. (2014) Alcohol and Liver Cancer: A Systematic Review and Meta-Analysis of Prospective Studies. Annals of Oncology, 25, 1526-1535. https://doi.org/10.1093/annonc/mdu020
|
[24]
|
Vatsalya, V., Liaquat, H.B., Ghosh, K., Mokshagundam, S.P. and McClain, C.J. (2016) A Review on the Sex Differences in Organ and System Pathology with Alcohol Drinking. Current Drug Abuse Reviews, 9, 87-92.
https://doi.org/10.2174/1874473710666170125151410
|
[25]
|
Bagnardi, V., Rota, M., Botteri, E., et al. (2015) Al-cohol Consumption and Site-Specific Cancer Risk: A Comprehensive Dose-Response Meta-Analysis. British Journal of Cancer, 112, 580-593. https://doi.org/10.1038/bjc.2014.579
|
[26]
|
侯经远, 谢运泉, 赵平森, 钟志雄. 中国南方客家人群乙醛脱氢酶2基因多态性与急性心肌梗死的相关性研究[J]. 分子诊断与治疗杂志, 2019, 11(3): 170-175.
|
[27]
|
Heckley, G.A., Jarl, J., Asamoah, B.O. and G-Gerdtham, U. (2011) How the Risk of Liver Cancer Changes after Alcohol Cessation: A Review and Meta-Analysis of the Current Literature. BMC Cancer, 11, Article No. 446.
https://doi.org/10.1186/1471-2407-11-446
|
[28]
|
Pang, Q., Qu, K., Zhang, J., et al. (2015) Cigarette Smoking In-creases the Risk of Mortality from Liver Cancer: A Clinical-Based Cohort and Meta-Analysis. Journal of Gastroenter-ology and Hepatology, 30, 1450-1460.
https://doi.org/10.1111/jgh.12990
|
[29]
|
Chuang, S.C., Amy, L.Y., Mia, H., Min, D., Zheng, T.Z. and Paolo, B. (2010) Interaction between Cigarette Smoking and Hepatitis B and C Virus Infection on the Risk of Liver Cancer: A Me-ta-Analysis. Cancer Epidemiology Biomarkers & Prevention, 19, 1261-1268. https://doi.org/10.1158/1055-9965.EPI-09-1297
|
[30]
|
Petrick, J.L., Campbell, P.T., Koshiol, J., et al. (2018) To-bacco, Alcohol Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pool-ing Project. British Journal of Cancer, 118, 1005-1012.
https://doi.org/10.1038/s41416-018-0007-z
|
[31]
|
Kanwal, F., Kramer, J.R., Mapakshi, S., et al. (2018) Risk of Hepatocellular Cancer in Patients with Non-Alcoholic Fatty Liver Disease. Gastroenterology, 155, 1828-1837.E2. https://doi.org/10.1053/j.gastro.2018.08.024
|
[32]
|
Reig, M., Gambato, M., Man, N.K., et al. (2019) Should Patients with NAFLD/NASH Be Surveyed for HCC. Transplantation, 103, 39-44. https://doi.org/10.1097/TP.0000000000002361
|
[33]
|
Kanwal, F., Kramer, J.R., Li, L., et al. (2020) Effect of Meta-bolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease. Hepatology, 71, 808-819. https://doi.org/10.1002/hep.31014
|
[34]
|
高娜, 左文韬, 李焕焕, 周永芹. 2型糖尿病与肝癌的关系[J]. 生命的化学, 2020, 40(1): 95-101.
|
[35]
|
Welzel, T.M., Graubard, B.I., Quraishi, S., et al. (2013) Population-Attributable Fractions of Risk Factors for Hepatocellular Carcinoma in the United States. American Journal of Gastroenterology, 108, 1314-1321.
https://doi.org/10.1038/ajg.2013.160
|
[36]
|
Simon, T.G., King, L.Y., Chong, D.Q., et al. (2018) Diabetes, Metabolic Comorbidities, and Risk of Hepatocellular Carcinoma: Results from Two Prospective Cohort Studies. Hepatology, 67, 1797-1806.
https://doi.org/10.1002/hep.29660
|
[37]
|
Kramer, J.R., Natarajan, Y., Dai, J., et al. (2022) Effect of Diabetes Medi-cations and Glycemic Control on Risk of Hepatocellular Cancer in Patients with Nonalcoholic Fatty Liver Disease. Hepatology, 75, 1420-1428.
https://doi.org/10.1002/hep.32244
|
[38]
|
Tina Landsvig, B., Michael, G., Claus, H., Thorkild, I.A.S. and Jennifer, L.B. (2014) Body Mass Index in Childhood and Adult Risk of Primary Liver Cancer. Journal of Hepatology, 60, 325-330.
https://doi.org/10.1016/j.jhep.2013.09.015
|
[39]
|
Florio, A.A., Campbell, P.T., Zhang, X., et al. (2020) Abdominal and Gluteofemoral Size and Risk of Liver Cancer: The Liver Cancer Pooling Project. International Journal of Cancer, 147, 675-685. https://doi.org/10.1002/ijc.32760
|
[40]
|
Chen, C.J., Yang, H.I., Su, J., et al. (2006) Risk of Hepato-cellular Carcinoma across a Biological Gradient of Serum Hepatitis B Virus DNA Level. JAMA, 295, 65-73. https://doi.org/10.1001/jama.295.1.65
|
[41]
|
Tran, K.T., Coleman, H.G., McCain, R.S. and Cardwell, C.R. (2019) Serum Biomarkers of Iron Status and Risk of Primary Liver Cancer: A Systematic Review and Meta-Analysis. Nutrition and Cancer, 71, 1365-1373.
https://doi.org/10.1080/01635581.2019.1609053
|
[42]
|
Porru, S., Placidi, D., Carta, A. and Alessio, L. (2006) Pre-vention of Injuries at Work: The Role of the Occupational Physician. International Archives of Occupational and Envi-ronmental Health, 79, 177-192.
https://doi.org/10.1007/s00420-005-0023-1
|